Exact Sciences Statistics

Total Valuation

Exact Sciences has a market cap or net worth of EUR 7.26 billion. The enterprise value is 8.69 billion.

Market Cap	7.26B
Enterprise Value	8.69B

Important Dates

The last earnings date was Monday, July 28, 2025.

Earnings Date	Jul 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	189.32M
Shares Outstanding	n/a
Shares Change (YoY)	+2.39%
Shares Change (QoQ)	+1.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	187.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	55.65
PS Ratio	2.90
PB Ratio	3.45
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 86.11, with an EV/FCF ratio of 60.17.

EV / Earnings	-10.15
EV / Sales	3.46
EV / EBITDA	86.11
EV / EBIT	n/a
EV / FCF	60.17

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 1.03.

Current Ratio	2.89
Quick Ratio	2.38
Debt / Equity	1.03
Debt / EBITDA	21.46
Debt / FCF	14.96
Interest Coverage	-4.84

Financial Efficiency

Return on equity (ROE) is -35.51% and return on invested capital (ROIC) is -1.58%.

Return on Equity (ROE)	-35.51%
Return on Assets (ROA)	-1.39%
Return on Invested Capital (ROIC)	-1.58%
Return on Capital Employed (ROCE)	-2.63%
Revenue Per Employee	360,197
Profits Per Employee	-123,158
Employee Count	7,000
Asset Turnover	0.47
Inventory Turnover	5.97

Taxes

Income Tax	-7.85M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	44.35
200-Day Moving Average	n/a
Relative Strength Index (RSI)	26.77
Average Volume (20 Days)	6

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.17

Income Statement

In the last 12 months, Exact Sciences had revenue of EUR 2.50 billion and -855.95 million in losses. Loss per share was -4.59.

Revenue	2.50B
Gross Profit	1.74B
Operating Income	-118.34M
Pretax Income	-863.80M
Net Income	-855.95M
EBITDA	66.66M
EBIT	-118.34M
Loss Per Share	-4.59

Full Income Statement

Balance Sheet

The company has 730.96 million in cash and 2.16 billion in debt, giving a net cash position of -1.43 billion.

Cash & Cash Equivalents	730.96M
Total Debt	2.16B
Net Cash	-1.43B
Net Cash Per Share	n/a
Equity (Book Value)	2.10B
Book Value Per Share	11.11
Working Capital	839.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 260.23 million and capital expenditures -115.80 million, giving a free cash flow of 144.43 million.

Operating Cash Flow	260.23M
Capital Expenditures	-115.80M
Free Cash Flow	144.43M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.63%, with operating and profit margins of -4.73% and -34.19%.

Gross Margin	69.63%
Operating Margin	-4.73%
Pretax Margin	-34.51%
Profit Margin	-34.19%
EBITDA Margin	2.66%
EBIT Margin	-4.73%
FCF Margin	5.77%

Dividends & Yields

Exact Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.39%
Shareholder Yield	n/a
Earnings Yield	-11.79%
FCF Yield	1.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exact Sciences has an Altman Z-Score of 1.37 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.37
Piotroski F-Score	5